| Financial Year |
March 31 2023 |
| Monetary Funds |
309,356,478.34 |
| Held-for-trading Financial Assets |
701,010,000.00 |
| Notes Receivable |
2,041,249.92 |
| Accounts Receivable |
437,833,710.70 |
| Advances to Suppliers |
19,384,889.56 |
| Other Receivables |
11,095,783.33 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
297,145,762.21 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
10,093,306.22 |
| Total Current Assets |
1,808,686,351.67 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
102,373,038.43 |
| Investment Properties |
-- |
| Fixed Assetes |
315,022,413.28 |
| Under-construction Projects |
32,229,333.37 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
109,484,765.91 |
| R&D expenses |
-- |
| Goodwill |
30,810,562.03 |
| Long-Term Deferred and Prepaid Expenses |
28,942,378.24 |
| Deferred Income Tax Assets |
22,008,483.42 |
| Other Non-Current Assets |
11,129,240.97 |
| Sub-Total of Non-Current Assets |
699,701,696.07 |
| Total Assets |
2,508,388,047.74 |
| Short-Term Loans |
13,810,980.22 |
| Trading Financial liabilities |
1,838,350.00 |
| Notes Payable |
-- |
| Accounts Payable |
145,680,368.66 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
38,792,855.69 |
| Taxes Payable |
10,802,730.38 |
| Interest Payable |
-- |
| Dividend Payable |
482,224.93 |
| Other payables |
9,480,147.31 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,782,999.68 |
| Other Current Liabilities |
1,838,036.30 |
| Sub-Total of Current Liabilities |
283,071,515.25 |
| Long-term Loans |
-- |
| Bonds Payable |
442,906,098.42 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
461,494.24 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
493,960,977.06 |
| Total Liabilities |
777,032,492.31 |
| Paid-In Capital(Or Share Stock) |
139,123,432.00 |
| Capital Surplus |
699,642,212.01 |
| Surplus Reserve |
88,084,737.94 |
| LESS:Treasury Stock |
57,530,523.37 |
| Undistributed Profits |
720,386,957.80 |
| Minority Stockholder's Interest |
37,933,412.70 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,693,422,142.73 |
| Owner's Equity（Stockholder's Equity） |
1,731,355,555.43 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,508,388,047.74 |
